Ahmed Nadim
Cullinan Therapeutics, Inc. · President and CEO
Ahmed Nadim is listed in public filings as director, officer: President and CEO. This Ahmed Nadim insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Cullinan Therapeutics, Inc. (CGEM), and Disc Medicine, Inc. (IRON). Investors use Ahmed Nadim's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $5.7M390.8k shares | SellFeb 24, 2026 | $195.6K13.5k shares | $14.47 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $5.5M404.3k shares | SellFeb 20, 2026 | $223.1K16.4k shares | $13.62 | -- | |
| $10M828k shares | Grant / ExerciseFeb 18, 2026 | $10.3M828k shares | $12.44 | -- | |
| $4.2M420.7k shares | SellDec 23, 2025 | $99.3K9.9k shares | $10.01 | -- | |
| $1.2M20k shares | Grant / ExerciseJul 14, 2025 | $1.2M20k shares | $57.74 | -- | |
| $3.7M430.6k shares | SellFeb 25, 2025 | $106.9K12.5k shares | $8.53 | -- | |
| $3.4M360k shares | Grant / ExerciseFeb 19, 2025 | $3.4M360k shares | $9.43 | -- | |
| --443.2k shares | Grant / ExerciseFeb 19, 2025 | Disclosure amount unavailable180k shares | -- | -- | |
| $3.1M263.2k shares | SellDec 24, 2024 | $99.7K8.4k shares | $11.87 | -- |